Nico M. Van Beveren

Rotterdam, ZH, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 50 publications

Baseline inflammatory profile is associated with short-term antipsychotic-induced weight gain in first-episode psychosis: results from the OPTiMiSE study.

Baseline inflammatory profile is associated with short-term antipsychotic-induced weight gain in first-episode psychosis: results from the OPTiMiSE study.

Journal: Schizophrenia research

Published: April 09, 2026

Correction: Psychiatrists effect on positive symptom severity and daily functioning during pharmacotherapy for first-episode psychosis patients.

Correction: Psychiatrists effect on positive symptom severity and daily functioning during pharmacotherapy for first-episode psychosis patients.

Journal: Scientific reports

Published: January 26, 2026

Early Dose Reduction or Discontinuation vs Maintenance Antipsychotics After First Psychotic Episode Remission: A Randomized Clinical Trial.

Early Dose Reduction or Discontinuation vs Maintenance Antipsychotics After First Psychotic Episode Remission: A Randomized Clinical Trial.

Journal: JAMA psychiatry

Published: October 01, 2025

Alterations in lipid, redox, and energy metabolism in recent onset psychosis: a metabolomics study in non-smoking individuals and matched controls.

Alterations in lipid, redox, and energy metabolism in recent onset psychosis: a metabolomics study in non-smoking individuals and matched controls.

Journal: Redox biology

Published: September 23, 2025

Antipsychotic plasma concentration as predictor of movement disorders and cardiometabolic side-effects: A comparison with prescription dose.

Antipsychotic plasma concentration as predictor of movement disorders and cardiometabolic side-effects: A comparison with prescription dose.

Journal: European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology

Published: September 12, 2025

Dopamine D2/3R availability after discontinuation of antipsychotic treatment: a [11C]raclopride PET study in remitted first-episode psychosis patients.

Dopamine D2/3R availability after discontinuation of antipsychotic treatment: a [11C]raclopride PET study in remitted first-episode psychosis patients.

Journal: Psychological medicine

Published: September 08, 2025

Risk of relapse during tapering of antipsychotic medication after a first psychotic episode: association with D2 receptor affinity but not with tapering speed.

Risk of relapse during tapering of antipsychotic medication after a first psychotic episode: association with D2 receptor affinity but not with tapering speed.

Journal: World psychiatry : official journal of the World Psychiatric Association (WPA)

Published: May 15, 2025

Autoantibodies against myelin oligodendrocyte glycoprotein in a subgroup of patients with psychotic symptoms.

Autoantibodies against myelin oligodendrocyte glycoprotein in a subgroup of patients with psychotic symptoms.

Journal: Frontiers in neurology

Published: March 13, 2025

The Effects of Antipsychotic Dose Reduction on Movement Disorders and Cardiometabolic Indices in Patients Remitted from a First Episode of Psychosis.

The Effects of Antipsychotic Dose Reduction on Movement Disorders and Cardiometabolic Indices in Patients Remitted from a First Episode of Psychosis.

Journal: Schizophrenia bulletin

Published: March 03, 2025

Obsessive-compulsive symptoms relating to psychosocial functioning for people with schizophrenia, schizoaffective disorder, or bipolar disorder.

Obsessive-compulsive symptoms relating to psychosocial functioning for people with schizophrenia, schizoaffective disorder, or bipolar disorder.

Journal: Acta neuropsychiatrica

Published: October 10, 2024

Potential benefits of ketone therapy as a novel immunometabolic treatment for schizophrenia.

Potential benefits of ketone therapy as a novel immunometabolic treatment for schizophrenia.

Journal: Psychiatry research

Published: May 22, 2024

Antipsychotic dopamine D2 affinity and negative symptoms in remitted first episode psychosis patients.

Antipsychotic dopamine D2 affinity and negative symptoms in remitted first episode psychosis patients.

Journal: Schizophrenia research

Published: May 07, 2024

Showing 1-12 of 50

Last Updated: 09/26/2026